Banner

First Vyluma product tackles pediatric myopia

Video

Dive deep into Vyluma’s investigational atropine therapy. Navneet Puri, PhD, the company’s founder, chairman, and CEO, explains details of the clinical trials.

Related Videos
Brianna Rhue, OD, FAAO, FSLS
Justin Kwan, OD, FAAO
Kevin Chan, OD, MS, FAAO, presents "Top 5 myopia management myths and how to overcome them" at AOA 2023 in Washington DC
Related Content

Multifocals for all ages

September 5th 2023

Debunking common ortho-k myths

October 6th 2022

The confusion surrounding atropine use to control myopia

August 30th 2023

Podcast: Sheila Morrison, OD reviews the latest in myopia management, part 2

December 1st 2021

The American Academy of Optometry (AAO) selected Dr Vera-Diaz to represent them at National Academies of Sciences, Engineering, and Medicine

August 18th 2023

New campaign highlights the importance of annual pediatric eye exams

August 4th 2023

Multifocals for all ages

September 5th 2023

Debunking common ortho-k myths

October 6th 2022

The confusion surrounding atropine use to control myopia

August 30th 2023

Podcast: Sheila Morrison, OD reviews the latest in myopia management, part 2

December 1st 2021

The American Academy of Optometry (AAO) selected Dr Vera-Diaz to represent them at National Academies of Sciences, Engineering, and Medicine

August 18th 2023

New campaign highlights the importance of annual pediatric eye exams

August 4th 2023

Multifocals for all ages

September 5th 2023

Debunking common ortho-k myths

October 6th 2022

The confusion surrounding atropine use to control myopia

August 30th 2023

Podcast: Sheila Morrison, OD reviews the latest in myopia management, part 2

December 1st 2021

The American Academy of Optometry (AAO) selected Dr Vera-Diaz to represent them at National Academies of Sciences, Engineering, and Medicine

August 18th 2023

New campaign highlights the importance of annual pediatric eye exams

August 4th 2023
© 2023 MJH Life Sciences

All rights reserved.